InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by White William Richard, Chief Financial Officer. Insider active across 1 companies, notably Akero Therapeutics, Inc.. In total, 20 disclosures have been published. The latest transaction was filed on 14 January 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Declarations20 total
10,179 shares
Common Stock
SEC:0001193125-25-312109·
10,179 shares
Common Stock
SEC:0001193125-25-312109:0·
€59,3419,700 shares@ €6.117619.9% of flow
Common Stock
SEC:0001104659-22-005080·
€59,3419,700 shares@ €6.11769.9% of flow
Common Stock
SEC:0001104659-22-005080:0·
€622100 shares@ €6.2150.2% of flow
Common Stock
SEC:0001104659-21-153316·
€622100 shares@ €6.2150.1% of flow
Common Stock
SEC:0001104659-21-153316:0·
€19,7893,200 shares@ €6.1846.6% of flow
Common Stock
SEC:0001104659-21-151760·
€19,7893,200 shares@ €6.1843.3% of flow
Common Stock
SEC:0001104659-21-151760:0·
€39,4226,500 shares@ €6.064913.2% of flow
Common Stock
SEC:0001104659-21-133649·
€39,4226,500 shares@ €6.06496.6% of flow
Common Stock
SEC:0001104659-21-133649:0·
€39,3616,500 shares@ €6.055613.2% of flow
Common Stock
SEC:0001104659-21-123087·
€39,3616,500 shares@ €6.05566.6% of flow
Common Stock
SEC:0001104659-21-123087:0·
€50,6638,559 shares@ €5.919317.0% of flow
Common Stock
SEC:0001104659-21-112969·
€50,6638,559 shares@ €5.91938.5% of flow
Common Stock
SEC:0001104659-21-112969:0·
€26,2134,441 shares@ €5.90258.8% of flow
Common Stock
SEC:0001104659-21-100188·
€26,2134,441 shares@ €5.90254.4% of flow
Common Stock
SEC:0001104659-21-100188:0·
€38,5296,500 shares@ €5.927512.9% of flow
Common Stock
SEC:0001104659-21-090367·
€38,5296,500 shares@ €5.92756.5% of flow
Common Stock
SEC:0001104659-21-090367:0·
€24,4074,200 shares@ €5.81128.2% of flow
Common Stock
SEC:0001104659-21-060965·
€24,4074,200 shares@ €5.81124.1% of flow
Common Stock
SEC:0001104659-21-060965:0·
20 of 20 declarations
About White William Richard
William Richard White is the Chief Financial Officer of Akero Therapeutics, Inc.
